Apyx Medical Corporation (APYX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -572K | -2.53M | -3.54M | -1.23M | -702K | -2.94M | -4.44M | -4.33M | -6.34M | -458K | 3.7M | -4.85M |
| Operating CF Margin % | -4.58% | -13.2% | -27.46% | -10.84% | -7.44% | -20.65% | -38.65% | -35.63% | -61.9% | -3.12% | 30.86% | -35.76% |
| Operating CF Growth % | 18.52% | 13.86% | 20.36% | 71.52% | 88.93% | -541.27% | -220.13% | 10.78% | -237.11% | 89.89% | 168.96% | 17.37% |
| Net Income | -2.11M | -1.22M | -1.98M | -3.74M | -4.15M | -4.66M | -4.77M | -6.56M | -7.58M | -9.61M | -4.67M | -1.02M |
| Depreciation & Amortization | 202K | 221K | 164K | 132K | 138K | 142K | 144K | 156K | 157K | 152K | 186K | 151K |
| Stock-Based Compensation | 0 | 500K | 0 | 520K | 451K | 838K | 997K | 1.05M | 1.13M | 914K | 1.35M | 1.48M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.96M | 208K | 0 |
| Other Non-Cash Items | 545K | 725K | 1M | 560K | 266K | 1.14M | -428K | 321K | 265K | 7.79M | 179K | -2.15M |
| Working Capital Changes | 789K | -2.76M | -2.72M | 1.29M | 2.59M | -394K | -385K | 700K | -315K | 2.25M | 6.45M | -3.31M |
| Change in Receivables | 3.95M | -3.9M | -1.84M | 471K | 3.94M | -2.91M | -308K | -291K | 1.48M | -1.38M | -751K | -2.28M |
| Change in Inventory | -845K | 511K | -865K | -521K | -199K | 1.36M | 355K | 409K | 138K | 1.06M | -133K | -345K |
| Change in Payables | -411K | -155K | 328K | 513K | -331K | 756K | -474K | 254K | -599K | 638K | -587K | 750K |
| Cash from Investing | -60K | -275K | -519K | -265K | -55K | -245K | -153K | -289K | -35K | -93K | -174K | 7.11M |
| Capital Expenditures | -60K | -275K | -519K | -265K | -55K | -245K | -153K | -289K | -35K | -93K | -174K | -156K |
| CapEx % of Revenue | 0.48% | 1.44% | 4.03% | 2.33% | 0.58% | 1.72% | 1.33% | 2.38% | 0.34% | 0.63% | 1.45% | 1.15% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.41M | 147K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.41M | -147K | 7.27M |
| Cash from Financing | 83K | 9.48M | 45K | 25K | 25K | 6.76M | -5K | -5K | -5K | 22.09M | 164K | 46K |
| Debt Issued (Net) | -5K | -6K | -4K | -5K | -5K | -5K | -5K | -5K | -5K | 20.04M | -13K | -10K |
| Equity Issued (Net) | 88K | 9.49M | 49K | 0 | 0 | 6.78M | 0 | 0 | 0 | 2.05M | 30K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 30K | 30K | -11K | 0 | 0 | 0 | 0 | 147K | 56K |
| Net Change in Cash | -603K | 6.61M | -4.17M | -1.71M | -730K | 3.73M | -4.67M | -4.6M | -6.37M | 21.52M | 3.65M | 2.22M |
| Free Cash Flow | -632K | -2.81M | -4.05M | -1.5M | -757K | -3.18M | -4.59M | -4.62M | -6.38M | -551K | 3.52M | -5.01M |
| FCF Margin % | -5.06% | -14.64% | -31.49% | -13.17% | -8.03% | -22.37% | -39.98% | -38.01% | -62.24% | -3.76% | 29.41% | -36.91% |
| FCF Growth % | 16.51% | 11.85% | 11.71% | 67.56% | 88.13% | -477.5% | -230.41% | 7.79% | -220.24% | 88.21% | 163.48% | 20.17% |
| FCF per Share | -0.01 | -0.07 | -0.10 | -0.04 | -0.02 | -0.08 | -0.13 | -0.13 | -0.18 | -0.02 | 0.10 | -0.14 |
| FCF Conversion (FCF/Net Income) | 0.27x | 1.95x | 1.78x | 0.33x | 0.17x | 0.63x | 0.94x | 0.66x | 0.84x | 0.05x | -0.80x | 4.88x |
| Interest Paid | 0 | 1.16M | 1.17M | 1.16M | 1.15M | -2.37M | 1.21M | 1.2M | 1.18M | 1.1M | 403K | 430K |
| Taxes Paid | 0 | 178K | 4K | 75K | 1K | -211K | 31K | 174K | 6K | 68K | 34K | 102K |